About Cony D'cruz
Cony D'cruz is a co-founder & CEO, director at Superluminal Medicines.
Cony D'cruz first appears on SEC filings in 2023.
Experience
This experience comes from Cony D'cruz's profile and from SEC filings. For roles taken from filings, the years are when the filings name Cony D'cruz in the role, so the role may have started earlier or lasted longer.
Superluminal Medicines, Inc.
Co-Founder & CEO, director
Chief Executive Officer
2023 – 2026 · Boston, MA
Develops small-molecule medicines for people with obesity and cardiometabolic diseases.
Key Colleagues at Startups
The people Cony D'cruz works with at each company, as listed on that company's latest Form D.
Superluminal Medicines, Inc. · Form D, Sep 3, 2026
HP
Harsha Paladugu
Director
DX
Diamantis Xylas
Director
DM
Dylan Morris
Managing Director at Insight Partners
NS
Nandita Shangari
Director